The structural similarity between p53 and its homologues p63 and p73, especially concerning their DBDs, suggests that anticancer molecules able to bind to p53 could also bind to either p63 or p73 and potentially enhance their tumor suppressive activity. Here, TP53 is linked to neoplasm.